I provide focused biotech expert interviews and research support for consulting teams, investors, biotech companies, and pharmaceutical teams. Engagements can cover cell and gene therapy, CRISPR, mRNA, viral vectors, preclinical development, Discovery-to-IND strategy, China market context, and technical landscape questions.
You can use this service for a 30–60 minute expert call, a structured questionnaire, targeted desk research, or a concise written follow-up. Before we begin, we will agree on the exact question, audience, deliverable, timing, and permitted sources. I will clearly separate evidence, professional judgment, assumptions, risks, and unanswered questions.
I have more than 15 years of life-science research and industry experience, including advanced-therapy program leadership through China and U.S. IND milestones and nonclinical interactions with the CDE and FDA.
I do not provide legal opinions, medical advice, regulatory guarantees, academic ghostwriting, or confidential information from former employers or clients.